Acrobiosystems Statistics
Total Valuation
Acrobiosystems has a market cap or net worth of CNY 7.60 billion. The enterprise value is 6.37 billion.
| Market Cap | 7.60B |
| Enterprise Value | 6.37B |
Important Dates
The last earnings date was Tuesday, April 21, 2026.
| Earnings Date | Apr 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Acrobiosystems has 167.18 million shares outstanding. The number of shares has decreased by -3.26% in one year.
| Current Share Class | 167.18M |
| Shares Outstanding | 167.18M |
| Shares Change (YoY) | -3.26% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | 36.79% |
| Owned by Institutions (%) | 17.53% |
| Float | 90.32M |
Valuation Ratios
The trailing PE ratio is 44.85 and the forward PE ratio is 29.12.
| PE Ratio | 44.85 |
| Forward PE | 29.12 |
| PS Ratio | 9.07 |
| PB Ratio | 2.86 |
| P/TBV Ratio | 2.90 |
| P/FCF Ratio | 50.48 |
| P/OCF Ratio | 21.38 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.29, with an EV/FCF ratio of 42.30.
| EV / Earnings | 38.49 |
| EV / Sales | 8.02 |
| EV / EBITDA | 32.29 |
| EV / EBIT | 45.19 |
| EV / FCF | 42.30 |
Financial Position
The company has a current ratio of 9.23, with a Debt / Equity ratio of 0.03.
| Current Ratio | 9.23 |
| Quick Ratio | 7.65 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.34 |
| Debt / FCF | 0.57 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.26% and return on invested capital (ROIC) is 14.48%.
| Return on Equity (ROE) | 6.26% |
| Return on Assets (ROA) | 4.16% |
| Return on Invested Capital (ROIC) | 14.48% |
| Return on Capital Employed (ROCE) | 6.99% |
| Weighted Average Cost of Capital (WACC) | 8.78% |
| Revenue Per Employee | 964,462 |
| Profits Per Employee | 190,527 |
| Employee Count | 869 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 0.32 |
Taxes
In the past 12 months, Acrobiosystems has paid 4.48 million in taxes.
| Income Tax | 4.48M |
| Effective Tax Rate | 2.65% |
Stock Price Statistics
The stock price has increased by +33.82% in the last 52 weeks. The beta is 0.84, so Acrobiosystems's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +33.82% |
| 50-Day Moving Average | 45.90 |
| 200-Day Moving Average | 54.29 |
| Relative Strength Index (RSI) | 45.85 |
| Average Volume (20 Days) | 5,207,117 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Acrobiosystems had revenue of CNY 838.12 million and earned 165.57 million in profits. Earnings per share was 0.99.
| Revenue | 838.12M |
| Gross Profit | 763.99M |
| Operating Income | 196.96M |
| Pretax Income | 169.32M |
| Net Income | 165.57M |
| EBITDA | 243.30M |
| EBIT | 196.96M |
| Earnings Per Share (EPS) | 0.99 |
Balance Sheet
The company has 1.35 billion in cash and 86.40 million in debt, giving a net cash position of 1.26 billion or 7.53 per share.
| Cash & Cash Equivalents | 1.35B |
| Total Debt | 86.40M |
| Net Cash | 1.26B |
| Net Cash Per Share | 7.53 |
| Equity (Book Value) | 2.66B |
| Book Value Per Share | 15.85 |
| Working Capital | 1.60B |
Cash Flow
In the last 12 months, operating cash flow was 355.74 million and capital expenditures -205.08 million, giving a free cash flow of 150.66 million.
| Operating Cash Flow | 355.74M |
| Capital Expenditures | -205.08M |
| Depreciation & Amortization | 50.72M |
| Net Borrowing | 3.92M |
| Free Cash Flow | 150.66M |
| FCF Per Share | 0.90 |
Margins
Gross margin is 91.16%, with operating and profit margins of 23.50% and 19.75%.
| Gross Margin | 91.16% |
| Operating Margin | 23.50% |
| Pretax Margin | 20.20% |
| Profit Margin | 19.75% |
| EBITDA Margin | 29.03% |
| EBIT Margin | 23.50% |
| FCF Margin | 17.98% |
Dividends & Yields
This stock pays an annual dividend of 0.57, which amounts to a dividend yield of 1.25%.
| Dividend Per Share | 0.57 |
| Dividend Yield | 1.25% |
| Dividend Growth (YoY) | -4.44% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 51.67% |
| Buyback Yield | 3.26% |
| Shareholder Yield | 4.52% |
| Earnings Yield | 2.18% |
| FCF Yield | 1.98% |
Stock Splits
The last stock split was on July 11, 2025. It was a forward split with a ratio of 1.4.
| Last Split Date | Jul 11, 2025 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |